Recce Pharmaceuticals Ltd
ASX:RCE

Watchlist Manager
Recce Pharmaceuticals Ltd Logo
Recce Pharmaceuticals Ltd
ASX:RCE
Watchlist
Price: 0.595 AUD -2.46% Market Closed
Updated: May 20, 2024

Recce Pharmaceuticals Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Recce Pharmaceuticals Ltd
Cash from Investing Activities Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
C
CU6

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Recce Pharmaceuticals Ltd
ASX:RCE
Cash from Investing Activities
-AU$530.5k
CAGR 3-Years
-122%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Cash from Investing Activities
AU$473.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Cash from Investing Activities
-AU$211.5m
CAGR 3-Years
-3 179%
CAGR 5-Years
N/A
CAGR 10-Years
-171%
Botanix Pharmaceuticals Ltd
ASX:BOT
Cash from Investing Activities
-AU$16.7m
CAGR 3-Years
-902%
CAGR 5-Years
-332%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Cash from Investing Activities
-AU$14.4m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Cash from Investing Activities
AU$3.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Recce Pharmaceuticals Ltd's Cash from Investing Activities?
Cash from Investing Activities
-530.5k AUD

Based on the financial report for Dec 31, 2023, Recce Pharmaceuticals Ltd's Cash from Investing Activities amounts to -530.5k AUD.

What is Recce Pharmaceuticals Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-42%

The average annual Cash from Investing Activities growth rates for Recce Pharmaceuticals Ltd have been -122% over the past three years , -42% over the past five years .